ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1765

CD8+ T Cells and Monocytes from Children with Macrophage Activation Syndrome Demonstrate Specific Transcriptional Changes Consistent with T Cell Activation and Expansion of Monocytes Shaped by Interferon and TLR Signaling

Susan Canny1, Hannah DeBerg2, Griffin Gessay2, Ailing Lu3, Mary Eckert4, Andrea La Bella5, Hayley Waterman2, Danish Nadeem2, Susan Shenoi6, Joyce Hui-Yuen7, Daniel Campbell2, Betsy Barnes8 and Jessica Hamerman2, 1University of Washington, Seattle, WA, 2Benaroya Research Institute, Seattle, WA, 3Northwell Health, Manhasset, NY, 4Seattle Children's Hospital, Seattle, WA, 5Cohen Children's Medical Center, Queens, NY, 6Seattle Children's Hospital and Research Center, Mercer Island, WA, WA, 7North Shore LIJ Health System, Great Neck, NY, 8Feinstein Institutes for Medical Science, Manhasset, NY

Meeting: ACR Convergence 2024

Keywords: cytokines, Juvenile idiopathic arthritis, macrophage activation syndrome, Monocytes/macrophages, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Macrophage activation syndrome (MAS), a form of secondary hemophagocytic lymphohistiocytosis (sHLH), is a potentially fatal complication of rheumatic diseases. MAS is characterized by a dysfunctional hyperinflammatory response in which there is abnormal activation of lymphocytes and phagocytes, leading to an overproduction of inflammatory cytokines and damage to host tissues. Circulating monocytes are highly responsive to their surrounding environment, are known to exhibit phenotypic and functional changes during inflammation, and can give rise to macrophages that phagocytose immune cells. However, monocytes and macrophages have not been well-studied in MAS. MAS is most commonly associated with systemic juvenile idiopathic arthritis (sJIA). At least 10% of sJIA patients will experience an overt episode of MAS with up to 50% exhibiting signs of subclinical inflammation. CD8+ T cells play a critical role during MAS through the secretion of the cytokine, interferon gamma (IFNg), which drives myeloid cell activation and excessive cytokine secretion. Expansion of a subpopulation of CD8+ T cells has recently been described in individuals with active sHLH/MAS which are CD38+ HLA-DR+.

Methods: Subjects with MAS were defined based on the 2016 classification criteria by Ravelli and colleagues as well as the ratio of ferritin to ESR. We analyzed monocytes from children with MAS (n=8) or age/sex/race-matched healthy children (n=4) by single cell RNA sequencing (scRNA-Seq). We analyzed lymphocytes from children with MAS (n=6) or healthy children (n=2) by scRNA-Seq. To generate TLR gene sets in monocytes, we isolated CD14+ monocytes by positive selection from 8 healthy controls, incubated them with TLR2, TLR4, TLR7, or TLR8 specific agonists, and analyzed the specific transcriptional signature using RNA sequencing.

Results: We identified a cluster of monocytes with evidence of interferon stimulation defined by high levels of interferon stimulated genes (ISGs). This ISG high cluster of monocytes was expanded in subjects with MAS as compared to healthy controls. We found evidence of both type I and type II interferons contributing to the gene signature in this cluster. We have generated specific TLR signatures in CD14+ monocytes to test whether specific TLRs contribute to the unique signature we identified in circulating monocytes during MAS. Lymphocytes from subjects with MAS revealed profound expansion of a CD8+ T cell subpopulation expressing markers of activation and exhaustion including LAG3, CTLA-4, and PD-1 as well as CD38 and HLA-DRA and were the primary source of IFNg.

Conclusion: These data provide evidence of a role for type I IFNs as well as TLRs in monocytes during MAS. Further our data identify expansion of a specific subpopulation of CD8+ T cells during MAS that is the primary source of IFNg. Together, our data show that CD14+ monocytes and CD8+ T cells have specific transcriptional signatures during MAS that likely contribute to pathophysiology.


Disclosures: S. Canny: None; H. DeBerg: None; G. Gessay: None; A. Lu: None; M. Eckert: None; A. La Bella: None; H. Waterman: None; D. Nadeem: None; S. Shenoi: cabletta, 2, Cure JM Foundation, 12, COE support at SCH, Pfizer, 2; J. Hui-Yuen: None; D. Campbell: None; B. Barnes: None; J. Hamerman: None.

To cite this abstract in AMA style:

Canny S, DeBerg H, Gessay G, Lu A, Eckert M, La Bella A, Waterman H, Nadeem D, Shenoi S, Hui-Yuen J, Campbell D, Barnes B, Hamerman J. CD8+ T Cells and Monocytes from Children with Macrophage Activation Syndrome Demonstrate Specific Transcriptional Changes Consistent with T Cell Activation and Expansion of Monocytes Shaped by Interferon and TLR Signaling [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/cd8-t-cells-and-monocytes-from-children-with-macrophage-activation-syndrome-demonstrate-specific-transcriptional-changes-consistent-with-t-cell-activation-and-expansion-of-monocytes-shaped-by-interfe/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cd8-t-cells-and-monocytes-from-children-with-macrophage-activation-syndrome-demonstrate-specific-transcriptional-changes-consistent-with-t-cell-activation-and-expansion-of-monocytes-shaped-by-interfe/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology